Related Experiment Video

Updated: Jul 18, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Inhibitors of the TGF-beta superfamily and their clinical applications

K Tsuchida1, Y Sunada, S Noji

  • 1Division for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan. tsuchida@fujita-hu.ac.jp

Mini Reviews in Medicinal Chemistry
|November 15, 2006
PubMed

Insights

Transforming growth factor-beta (TGF-beta) superfamily inhibitors are crucial for regulating TGF-beta activity. This review details recent advances in understanding these inhibitors and their therapeutic applications in various diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • The transforming growth factor-beta (TGF-beta) superfamily encompasses critical signaling molecules like TGF-betas, activin, myostatin, and bone morphogenetic proteins.
  • Dysregulation of TGF-beta family members is implicated in the pathogenesis of cancer, muscular dystrophy, obesity, and bone/tooth remodeling disorders.
  • Natural inhibitors play a vital role in fine-tuning TGF-beta family activity in vivo.

Purpose of the Study:

  • To review recent advancements in the understanding of inhibitors targeting the TGF-beta superfamily.
  • To summarize the medical applications of these TGF-beta superfamily inhibitors.

Main Methods:

  • Literature review of recent research on TGF-beta superfamily inhibitors.
  • Analysis of natural inhibitors, soluble receptor forms, monoclonal antibodies, and small chemical inhibitors.
  • Examination of the therapeutic potential and applications of identified inhibitors.

Main Results:

  • Recent progress has been made in identifying and characterizing various classes of TGF-beta superfamily inhibitors.
  • Soluble receptors, monoclonal antibodies, and small chemical inhibitors represent key therapeutic strategies.
  • These inhibitors demonstrate potential in modulating diseases linked to TGF-beta misregulation.

Conclusions:

  • Inhibitors of the TGF-beta superfamily are essential for controlling signaling pathways involved in numerous diseases.
  • Continued research into these inhibitors holds significant promise for developing novel medical treatments.
  • Targeting TGF-beta signaling pathways offers a viable therapeutic avenue for conditions ranging from cancer to metabolic and bone disorders.

More Related Videos

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...